Halozyme Therapeutics
HALO
#2096
Rank
NZ$12.12 B
Marketcap
$98.12
Share price
0.34%
Change (1 day)
50.09%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): NZ$0.93 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are NZ$1.01 Billion. , an increase over its 2023 earnings that were of NZ$0.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.93 B59.94%
2023 NZ$0.58 B39.94%
2022 NZ$0.41 B0.16%
2021 NZ$0.41 B92.2%
2020 NZ$0.21 B-278.96%
2019 -NZ$0.13 Billion-9.45%
2018 -NZ$0.14 Billion-229.51%
2017 NZ$0.10 B-160.48%
2016 -NZ$0.18 Billion216.03%
2015 -NZ$54.15 Million-52.86%
2014 -NZ$0.12 Billion-18.09%
2013 -NZ$0.15 Billion55.88%
2012 -NZ$89.97 Million169.94%
2011 -NZ$33.33 Million-63.44%
2010 -NZ$91.15 Million-7.19%
2009 -NZ$98.21 Million15.91%
2008 -NZ$84.73 Million83.89%
2007 -NZ$46.08 Million78.1%
2006 -NZ$25.88 Million16%
2005 -NZ$22.31 Million45.24%
2004 -NZ$15.36 Million682.42%
2003 -NZ$1.97 Million1659.12%
2002 -NZ$0.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$51.26 M-94.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.30 B 2,176.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1 Billion-206.44%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$18.66 B 1,894.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.34 B 1,325.52%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$29.30 B 3,030.68%๐Ÿ‡บ๐Ÿ‡ธ USA